Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin lispro update.

Jerry D Meece1, R Keith Campbell2

  • 1Washington State University, College of Pharmacy, Department of Pharmacy Practice, Pullman, Washington, USA.

The Diabetes Educator
|April 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacotherapy of Diabetes: Past, Present, and Future: Preface.

Diabetes spectrum : a publication of the American Diabetes Association·2015
Same author

Complementary Approaches to Improving Glucose Control-Insulin and Incretins: Patient Case Studies in Action.

The Diabetes educator·2014
Same author

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.

Adolescent health, medicine and therapeutics·2014
Same author

Can a new ultra-long-acting insulin analogue improve patient care? Investigating the potential role of insulin degludec.

Drugs·2012
Same author

Recommendations for improving adherence to type 2 diabetes mellitus therapy--focus on optimizing insulin-based therapy.

The American journal of managed care·2012
Same author

Clinical efficacy of colesevelam in type 2 diabetes mellitus.

Journal of pharmacy practice·2011

Insulin lispro offers significant advantages over regular insulin for diabetes management. It effectively lowers hemoglobin A1C and reduces hypoglycemia in diverse patient groups, including pediatric and pregnant individuals.

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Diabetes mellitus management requires effective glycemic control.
  • Insulin therapy is a cornerstone of diabetes treatment.
  • Rapid-acting insulins offer potential benefits over traditional formulations.

Purpose of the Study:

  • To review the literature and clinical studies on insulin lispro.
  • To update information on the advantages of insulin lispro compared to regular insulin.
  • To assess the efficacy and safety of insulin lispro in various diabetic populations.

Main Methods:

  • Literature search of Medline articles.
  • Review of clinical studies on insulin lispro.
  • Analysis of patient outcomes including hemoglobin A1C and hypoglycemia episodes.

Related Experiment Videos

Main Results:

  • Insulin lispro demonstrated a greater reduction in hemoglobin A1C compared to regular insulin.
  • Patients using insulin lispro experienced fewer episodes of hypoglycemia.
  • These benefits were observed in various special populations with diabetes.

Conclusions:

  • Insulin lispro's faster onset and shorter duration of action enhance glycemic control.
  • It is effective in lowering A1C values and reducing hypoglycemic events.
  • Insulin lispro is beneficial for pediatric patients, pregnant women, those with gastroparesis, and insulin pump users.